A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Cachexia

In brief

This study will examine whether a single dose of PF-05230901 is safe and well tolerated when given to healthy volunteers by injection under the skin. An additional objective is to measure the blood concentrations of PF-05230901. Each dose will be tested in a different group of subjects starting from the lowest dose.

Key facts

Study ID

NCT01262690

Run by

Pfizer

People needed

44

Starts

2010-11-01

Expected to finish

2011-09-01

Last updated by the study team

2011-10-12

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subjects

You may not qualify if…

• History of seizures, including childhood seizures.
• History of movement disorders or related neurological conditions.
• History of head trauma associated with loss of consciousness.

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.